Takeda Pharmaceutical Co Ltd


By |


Takeda is Japan's largest pharmaceutical company, with annual revenue around $16 billion and a focus on four therapeutic areas: oncology, gastroenterology, vaccines, and neurology. Roughly 40% of its revenue comes from Japan. The Millennium acquisition (2008) brought rights to Velcade, Ninlaro, and Entyvio. The Nycomed acquisition (2011) expanded Takeda's exposure to Europe and emerging markets. Other notable products include Azilva (blood pressure), leuprorelin (prostate cancer), and Trintellix (depression).

Contact Information

Website: www.takeda.co.jp
Email: takeda.ir.contact@takeda.com
Main Phone: +81 662042111
Address: 4-1-1 Doshomachi
Address 2: Chuo-ku
City / Town: Osaka
Country: JPN
Postal Code: 540-8645

Issuer Information

Exchange: OTO
Employees: 27230
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 34.54 $ -0.32 (-0.92%)
Last Price 34.54 Change $ -0.32 Change % -0.92 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 34.63 High 34.63 Low 34.40 Prev Close 34.86
Last Trade Volume 1.4 mi 52 Wk Hi 60.11 52 Wk Low 32.43
Market Cap 27 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 781,322,895.00 EPS (TTM) 1.72 PE Ratio 18.90 Exchange OTCPK